132 related articles for article (PubMed ID: 34817883)
1. Risk of Pregabalin-Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database.
Yamada T; Mitsuboshi S; Makino J; Suzuki K; Nishihara M; Neo M
J Clin Pharmacol; 2022 Jun; 62(6):756-761. PubMed ID: 34817883
[TBL] [Abstract][Full Text] [Related]
2. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug event profile associated with pregabalin among patients with and without cancer: analysis of a spontaneous reporting database.
Kose E
J Clin Pharm Ther; 2018 Aug; 43(4):543-549. PubMed ID: 29574893
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM
Clin Drug Investig; 2021 Mar; 41(3):245-253. PubMed ID: 33580482
[TBL] [Abstract][Full Text] [Related]
6. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.
Kaul I; Amin A; Rosenberg M; Rosenberg L; Meyer WJ
Burns; 2018 Mar; 44(2):414-422. PubMed ID: 28822592
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
Vickers-Smith R; Sun J; Charnigo RJ; Lofwall MR; Walsh SL; Havens JR
Drug Alcohol Depend; 2020 Jan; 206():107709. PubMed ID: 31732295
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
9. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases.
Mukai R; Hasegawa S; Umetsu R; Nakao S; Shimada K; Uranishi H; Masuta M; Suzuki H; Nishibata Y; Nakamura M
J Clin Pharm Ther; 2019 Apr; 44(2):285-291. PubMed ID: 30569470
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.
Athanasakis K; Petrakis I; Karampli E; Vitsou E; Lyras L; Kyriopoulos J
BMC Neurol; 2013 Jun; 13():56. PubMed ID: 23731598
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of pharmacoeconomic studies for pregabalin.
Parker L; Huelin R; Khankhel Z; Wasiak R; Mould J
Pain Pract; 2015 Jan; 15(1):82-94. PubMed ID: 24815038
[TBL] [Abstract][Full Text] [Related]
16. Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients.
Dragic L; Webb T; Chandler M; Harrington SB; McDade E; Dayer L; Painter JT
J Pain Palliat Care Pharmacother; 2020 Dec; 34(4):192-196. PubMed ID: 32924715
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
[TBL] [Abstract][Full Text] [Related]
18. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice.
Saldaña MT; Pérez C; Navarro A; Masramón X; Rejas J
Clin Drug Investig; 2012 Jun; 32(6):401-12. PubMed ID: 22480279
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]